From owner-proteins@net.bio.net Sun Nov 01 22:00:00 1992
Path: biosci!agate!ames!elroy.jpl.nasa.gov!swrinde!cs.utexas.edu!uunet!digex.com!wbrown
From: wbrown@access.digex.com (William Brown)
Newsgroups: bionet.molbio.proteins
Subject: Re: Genetics transposons conventions...
Message-ID: <Bx3nAs.Dz8@access.digex.com>
Date: 2 Nov 92 17:30:27 GMT
References: <Bx2CrB.Fq0@access.digex.com> <1992Nov1.211151.1@uwovax.uwo.ca>
Sender: usenet@access.digex.com
Organization: Express Access Online Communications, Greenbelt, MD USA
Lines: 24
Nntp-Posting-Host: access.digex.com

In article <1992Nov1.211151.1@uwovax.uwo.ca> 37_1510@uwovax.uwo.ca writes:
>In article <Bx2CrB.Fq0@access.digex.com>, wbrown@access.digex.com (William Brown) writes:
>>     I hope somebody can help me with this problem.  My research is in
>> modeling, so I've gotten a little rusty on the genetics end of things. 
>> I'm reading a paper that includes the following descriptions of
>> transposons in its PROCEDURES section, and for the life of me I don't know
>> what they are talking about:  Hfr::Tn10, zcf::Tn10, and srl::Tn10.  I KNOW
>> what Tn10 is - a P1 phage-transfer unstable transposon carrying
>> tetracycline resistance.  I HAVE NO IDEA what the meanings of the
>> three-letter prefixes are.
>> 
>
>The three letter symbols correspond to the gene where the transposon is
>inserted. ie. srl=sorbitol. [...etc.]

>Miguel A. Valvano. Microbiology and Immunology, University of Western Ontario,
>London, Ontario.

   Thank you and the others who have replied.  The Hfr I figured
out, but the other two (epsecially the zcf) had me stumped. 
Thanks for the help.

    William Brown, Jr.
 

From owner-proteins@net.bio.net Mon Nov 02 22:00:00 1992
Path: biosci!NBRF.GEORGETOWN.EDU!POSTMASTER
From: POSTMASTER@NBRF.GEORGETOWN.EDU
Newsgroups: bionet.molbio.proteins
Subject: Announcements of PIR Network Request Service
Message-ID: <01GQPXXA18WA8WW08R@NBRF.Georgetown.Edu>
Date: 3 Nov 92 19:48:23 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 276


               Announcements of the Protein Information Resource
                            Network Request Service

Highlights
1. Hints for Retrieving Sequence Database Entries
2. PIR Network Request Service Command Summary


1. Hints for Retrieving Sequence Database Entries

The very first thing to appreciate about the sequence databases is that the
most commonly sought information for every entry is contained in the title
field.  The title field contains the protein name, the source organism and the
EC number if it's an enzyme.  On the other hand, the keyword field contains
information that does not necessarily duplicate what is in the title.  What the
keyword field is designed to do is provide ancillary retrieval information that
is not conveyed in a protein name, such information as
  * disease or resistance states associated with the protein
    ACQUIRED IMMUNE DEFICIENCY SYNDROME or CYANATE RESISTANCE
  * metabolic roles or pathways
    CALCIUM TRANSPORT or PENTOSE PHOSPHATE PATHWAY
  * posttranslation modification processes
    HYDROXYLATION
  * tissues, cell types or subcellular components that are the origin of or
    the targets of the protein
    HEART, LEUKOCYTE or MITOCHONDRIAL MATRIX
  * structural characteristics
    TRIMER or ZINC FINGER
  * larger classification schemes the protein may fall in
    SERINE PROTEASE or STRUCTURAL PROTEIN
Most searches are for information contained in the title field.  The most
common reason for a keyword search failure is that the protein name is what is
being used and that can be found in the title, not the keyword list.  A list of
the keywords found in the current public distribution release of the PIR can be
obtained by using the command
   SEND KEYWORDS
The keywords used by the PIR correspond closely to the MESH terms of the
National Library of Medicine.  

When only one field is being searched, all the words that follow the field name
must be found in the same entry for there to be a "hit".  This means that all
the words on one command line form a logical AND; a QUERY that repeats the same
field connected by AND is unnecessary.  Furthermore since the title combines
both the protein name and the source organism, the title and species can be
searched in a single command; for example,
   QUERY
   TITLE ALPHA
   AND
   TITLE HEMOGLOBIN
   AND
   SPECIES HUMAN
   END QUERY
can be simply combined as
   TITLE HUMAN ALPHA HEMOGLOBIN
On the other hand OR operations are just equivalent to combining the results
of several different searches; for example
   QUERY
   TITLE HUMAN ALPHA HEMOGLOBIN
   OR
   TITLE HUMAN DELTA HEMOGLOBIN
   END QUERY
would achieve the same result as the two separate TITLE searches.

The Boolean operators must be placed on separate lines and not on the line
with another command; for example,
   TITLE CYTOCHROME AND P450
will fail because only entries with the character string "AND" in the title
along with "CYTOCHROME" and "P450" will hit.
   TITLE CYTOCHROME P450
means "search for titles containing both strings 'CYTOCHROME' and 'P450'
in either order".  Double quotation marks can be used to change the meaning
slightly
   TITLE "CYTOCHROME P450"
means "search for titles containing the string 'CYTOCHROME P450' ".  The
double quotation marks must be used when some part of the search string
is less than 3 characters long; for example,
   TITLE "CYTOCHROME C"
The Boolean NOT command can be used most effectively to remove entries
with names that are extensions of some shorter name of interest; for example,
   QUERY
   TITLE "CYTOCHROME C "
   NOT
   TITLE OXIDASE
   NOT
   TITLE REDUCTASE
   END QUERY
will pretty much eliminate everything but cytochrome C from the resulting list. 
(Because the indexing scheme used by the retrieval program lumps together all
the nonalphanumeric characters, the space appearing after the "C" and before
the double quotation mark eliminates entries like "cytochrome c2" but not
"cytochrome c'" from the list.)

One very inappropriate type of request is the following.
   GENE CONCANAVALIN
   KEYWORD CONCANAVALIN
   FEATURE CONCANAVALIN
   TITLE CONCANAVALIN
   SEARCH CONCANAVALIN
Specifically, "concanavalin" is not a gene name, so it will not be found
in the gene field.  The word "concanavalin" is plain text, not a sequence,
so it should not appear after the SEARCH command --- only actual sequences
should appear after a SEARCH command.  While "concanavalin" might possibly
appear in the keyword or feature fields, its use there would be very
specialized and not indicative of a concanavalin entry.  The only command
that makes any sense is
  TITLE CONCANAVALIN
The biggest problem comes when the SEARCH command is used in that way.  The
futile FASTA search this generates wastes shared computer resources that can
be used by others much more fruitfully.  The FASTA program has been modified
to recognize some occurrences of plain text and print a warning.

The USE command is used to restrict searches to particular databases or to
entries added or modified within a particular time period.  Such restrictions
apply to all subsequent search commands in the same request and need not be
used only in queries.

After a successful search, the GET command should be used to retrieve the
actual text of an entry.  The format of the GET command is either
   GET database:code
 or simply
   GET code
There are no spaces around the colon and only one code may follow each GET
command.

There are a few special considerations to keep in mind when using the NRL_3D
database of sequence information extracted from the Brookhaven Protein Data
Bank.  Only these fields in NRL_3D are indexed and can be searched through the
PIR Server:  TITLE, SPECIES, FEATURE and the sequence.  At this time the TITLE
field consists of the COMPND records from the Brookhaven Protein Data Bank file
as well as the species.  In most cases your search will be for something in
this TITLE or name field.  For example, after an initial
   USE BASES NRL_3D
the command
   TITLE MYOGLOBLIN
will retrieve a list of all the myoglobin sequences in the PDB and
   SPECIES MOUSE
will retrieve a list of all the mouse sequences.  The SPECIES field is not 100%
accurate for the NRL_3D because of some eccentricities in the SOURCE records of
the PDB used to construct it.  Although there is a KEYWORD field in NRL_3D
entries, it is constructed directly from the PDB HEADER record and is not
indexed.

With release 10.00 of NRL_3D the PIR will cease converting all of each PDB 
release.  Instead only new and modified entries will be converted; the NRL_3D
entries will gradually be modified to standardize spelling, capitalization,
nomenclature, taxonomy and keywords.  With this standardization the KEYWORD
field will become more meaningful and probably be indexed within the coming
year.


2. PIR Network Request Service Command Summary

The National Biomedical Research Foundation Protein Information Resource
network request service is a full-function fileserver and database query
system.  Operating since August 1990 it is capable of handling database
queries, sequence searches and sequence submissions, in addition to
fileserver requests.  To use this server, request commands should be sent to
FILESERV@GUNBRF on BITNET or FILESERV@NBRF.Georgetown.EDU on Internet.
The server recognizes the following commands sent either in a mail message,
or (if the sender is on BITNET) in a command message or a file:

  Command        Action
  -------        -----------------------------------------------
  ACCESSION      list entry codes and titles by accession number
  AND            combine QUERY commands with Boolean AND
  AUTHOR         list entry codes and titles by author
  BASES          list accessible databases
  CROSS          list PIR entry codes and titles corresponding to
                   a particular nucleic sequence database entry
  DEPOSIT        deposit entry for database submission
    END DEPOSIT  terminate deposit entry
  FEATURE        list entry codes and titles by feature table entry
  GENE           list entry codes and titles for a gene name
  GET            return entry by entry code
  HELP           return HELP instructions
  HOST           list entry codes and titles by host species
  INDEX          list SENDable files
  JOURNAL        list entry codes and titles by journal citation
  KEYWORD        list entry codes and titles by keyword
  MEMBER         list alignments containing entry code as a member
  NOT            combine QUERY commands with Boolean NOT
  OR             combine QUERY commands with Boolean OR
  QUERY          begin collecting QUERY commands
    END QUERY    terminate collecting commands and execute QUERY
  QUIT           ignore the remaining text (E-mail signature blocks)
  RETURN         change return address for gateway mail
  SEARCH         search for matching sequences by FASTA procedure
    END SEARCH   terminate sequence for searching
  SEND           send file
  SPECIES        list entry codes and titles by species
  SUGGEST        leave suggestion or correction for PIR staff
    END SUGGEST  terminate suggestion text
  SUPERFAMILY    list entry codes and titles by superfamily name
  TAXONOMY       report taxonomy for scientific or common name
  TITLE          list entry codes and titles by title
  USE            set databases, dates or formats to use in limited searches

Multiple commands can be sent with one command on each line of a mail message
or file.  Commands should NOT be sent on the Subject line of a mail message.
Receipt of command messages and files will be acknowledged immediately.  Mail
messages will be acknowledged by return mail.

For help in using any of the commands, send a request of the form
  HELP topic
for example
  HELP SEARCH

In addition to the commands, help instructions are also available on the
following topics:
  Custom_Services
  Databases
  FTP
  Gateway_Access
  Help_en_Espanol
  Help_en_francais
  Hints
  IBM-VM_BITNET
  On-Line_Access
  PIR_Distribution
  VAX-VMS_BITNET

Because of network gateway communication protocols, there are limitations on
requests sent through gateways.  Users not on BITNET or INTERNET who access the
server through local or network gateways should read and carefully follow these
instructions before sending requests.  Only mail message requests (not command
messages or files) can be sent through gateways.  Because addresses posted on
gateway mail do not always work for the return, before you send requests
through network gateways it is strongly recommended that you first contact Dr.
John S. Garavelli (POSTMAST@GUNBRF on BITNET, POSTMASTER@NBRF.Georgetown.EDU on
Internet).  We will confirm a return address for you and may instruct you to
use the RETURN command to ensure that your request output will reach you.  It
is not usually necessary to do this if you are on BITNET or INTERNET, unless
your system employs a local remailer or your mail program applies a
nonstandard return address (for example a personal name on the FROM: line).

The BITNET network and the network gateways impose strict limits on file size.
Poorly posed database queries may result in output so extensive that it could
not be returned by network mail.  Therefore, an output limit of 1000 lines for
each command and 3000 lines for each request is imposed by the PIR server.

The DEPOSIT and QUERY commands, and the SEARCH and SUGGEST commands (in their
multiline form) must be followed by their respective END commands after the
text appearing on the intervening lines.  The DEPOSIT command requires, and the
SEARCH command optionally uses, parameters that appear on the same line as the
command.  Because these four commands are so complex, users should obtain and
carefully read the help instructions before attempting to use them.

The databases available through the PIR Network Server and their abbreviations
for code specification are as follows:
  Abbreviation  Database                              Update Schedule
  PIR1          PIR Annotated and Classified Entries  quarterly
  PIR2          PIR Preliminary Entries               approximately monthly
  PIR3          PIR Unverified Entries                weekly
  ALN           PIR Alignment Entries                 semiannually
  NRL_3D        Brookhaven Data Bank Sequences        quarterly
  PATCHX        MIPS PIR-Supplementary Database       quarterly
  N             NBRF Nucleic
  GB            GenBank (TM)                          as received
  GBSUP         GenBank (TM)                          as received
  GBNEW         GenBank (TM) New Entries              weekly
  EMBL          EMBL                                  as received
  EMBLSUP       EMBL                                  as received
In the FASTA output of the SEARCH command the abbreviation for PATCHX is
shortened to PATX and NRL_3D is shortened to NR3D; the longer abbreviation
should be used to retrieve an entry with the GET command.  Not all commands
work with all databases; please read the information returned by the command
HELP DATABASES.
------------------------------------------------------------------------
                                 Dr. John S. Garavelli
                                 Database Coordinator
                                 Protein Information Resource
                                 National Biomedical Research Foundation
                                 Washington, DC  20007
                                 POSTMASTER@GUNBRF.BITNET
                                 POSTMASTER@NBRF.Georgetown.Edu

From owner-proteins@net.bio.net Tue Nov 03 22:00:00 1992
Path: biosci!PB1.PDB.BNL.GOV!ABOLA
From: ABOLA@PB1.PDB.BNL.GOV
Newsgroups: bionet.molbio.proteins
Subject: Protein Data Bank on FTP
Message-ID: <921104163102.e46@PB1.PDB.BNL.GOV>
Date: 4 Nov 92 21:31:02 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 88

---------------------------------------------------------------------
            Protein Data Bank Announcement 
                      11/4/92
---------------------------------------------------------------------


Protein Data Bank via FTP 
-------------------------

Beginning immediately, all full-release and pre-release coordinate 
entries will be available from Brookhaven National Laboratory via
anonymous ftp and the PDB e-mail server.  As we expect a dramatic 
rise in the number of users downloading entries, we request that
users limit the number of files transferred during a given FTP session.
Those requiring a substantial number of entries should continue to
order the PDB on tape or CD ROM.  


File Server and Anonymous FTP
-----------------------------

At Brookhaven, the PDB has an e-mail file server available for your
use. This server provides PDB general information and documentation
files. For more information, send an e-mail message to
fileserv@pb1.pdb.bnl.gov and include the following text:

	send info your_e-mail_address.

The PDB also has an anonymous FTP account available on the 
system pdb.pdb.bnl.gov with Internet address 130.199.144.1. It is 
possible to transfer files to and from this system using "anony-
mous" as the FTP user name and your real user name as the pass-
word. PDB general information and documentation files, as well 
as pre-release atomic coordinate entries, are available for down-
loading. You also can upload any files that you may wish to send 
to the PDB. Those using VMS may need to place quotes around 
file names. 

Anyone experiencing problems or having questions related to the 
above network service should send an e-mail message to             
skora@bnl.gov.

Accessing PDB via Gopher
------------------------

The PDB anonymous FTP directories can now be accessed via the gopher 
service.  Those running the Gopher client can access the PDB FTP 
site by including the following link:

  Name= Protein Data Bank ftp Site
  Type=1
  Host=pdb.pdb.bnl.gov
  Port=70
  Path=1/

For more information or help in accessing PDB via Gopher, send an e-mail
message to oeder@bnl.gov/


To Contact the PDB
------------------

Please include your telephone number, facsimile number, mailing 
address, and e-mail address in all correspondence.


	Mail:	Protein Data Bank
		Chemistry Department, Building 555 
		Brookhaven National Laboratory
		Upton, NY 11973 USA


	Phone:	+1 516-282-3629
	Fax:	+1 516-282-5751

	e-mail:	pdb@bnlchm.bitnet
             or pdb@chm.chm.bnl.gov

---------------------------------------------------------------------
________________________________________________________________                                 
				 | 
enrique e. abola                 |   BITNET:    abola1@bnl
Protein Data Bank                |   INTERNET:  abola1@bnl.gov 
Department of Chemistry          |   (516)-282-4383 
Brookhaven National Laboratory   | 
Upton NY 11973                   |
________________________________________________________________ 


From owner-proteins@net.bio.net Sat Nov 07 22:00:00 1992
Path: biosci!agate!spool.mu.edu!uunet!noc.near.net!news.cs.brandeis.edu!binah.cc.brandeis.edu!DUCA
From: duca@binah.cc.brandeis.edu
Newsgroups: bionet.molbio.proteins
Subject: ...looking for just the right peptide...
Message-ID: <1992Nov8.133724.28617@news.cs.brandeis.edu>
Date: 8 Nov 92 13:37:24 GMT
Sender: news@news.cs.brandeis.edu (USENET News System)
Reply-To: duca@binah.cc.brandeis.edu
Organization: Brandeis University
Lines: 17

Hi there all you exquisitely architectured biological (and/or artificial)
        neural nets,

I'm trying to develop a theoretical model of ion channel formation within
a lipid bilayer.  I've settled on using certain "designer channels" made
by Lear and DeGrado at DuPont about 5-7 years ago, but unfortunately no
spectroscopy has been done on them and we don't have too clear an idea of
their structures.  Does anyone know of any serine and leucine rich alpha
helical proteins with good structural data available (X-ray or NMR)?
Seeing as initial parameter setting is so crucial in these models I want
to try to start with some known interatomic distances as first approximations.
Can anybody make a suggestion?  I'd really appreciate it.  Thanx in advance.

Karen Duca
Dept. of Biophysics
Brandeis U.
duca@binah.cc.brandeis.edu

From owner-proteins@net.bio.net Wed Nov 11 22:00:00 1992
Path: biosci!uwm.edu!zaphod.mps.ohio-state.edu!darwin.sura.net!convex!constellation!aardvark.ucs.uoknor.edu!bfrank
From: bfrank@aardvark.ucs.uoknor.edu (FRANK,BART)
Newsgroups: bionet.molbio.proteins
Subject: anti-GST antibodies for fusion protein detection
Message-ID: <12NOV199215143452@aardvark.ucs.uoknor.edu>
Date: 12 Nov 92 21:14:00 GMT
Sender: usenet@constellation.ecn.uoknor.edu (Usenet Administrator)
Organization: University of Oklahoma - University Computing Services
Lines: 9
Originator: usenet@midway.ecn.uoknor.edu
News-Software: VAX/VMS VNEWS 1.41

We are attempting to produce a GST fusion protein and either little
of it is made or little survives proteolysis.  We would like to 
demonstrate its presence by showing the expected increase in
molecular weight on a Western blot with an anti-GST antibody.
Can anyone recommend a source for such a reagent?

Thanks, 
Bart Frank
Internet: BFRANK@AARDVARK.UCS.UOKNOR.EDU

From owner-proteins@net.bio.net Thu Nov 12 22:00:00 1992
Path: biosci!agate!doc.ic.ac.uk!mrccrc!warwick!pavo.csi.cam.ac.uk!cy-mac.welc.cam.ac.uk!cyk10
From: cyk10@cus.cam.ac.uk (C-Y Khoo)
Newsgroups: bionet.molbio.proteins
Subject: anti-GST antibodies for fusion protein detection
Message-ID: <1992Nov13.121349.23095@infodev.cam.ac.uk>
Date: 13 Nov 92 12:13:49 GMT
References: <12NOV199215143452@aardvark.ucs.uoknor.edu>
Sender: news@infodev.cam.ac.uk (USENET news)
Organization: Wellcome/CRC Institute, Cambridge
Lines: 34
X-Xxmessage-Id: <A7294C7D4C012D4A@cy-mac.welc.cam.ac.uk>
X-Xxdate: Fri, 13 Nov 92 12:13:49 GMT
Nntp-Posting-Host: cy-mac.welc.cam.ac.uk
X-Useragent: Nuntius v1.1.1d11

I too, have been looking for anti-GST antibodies, but without any success.
I called Pharmacia and they said that they are in the process of
developing
such a reagent, but that it won't be ready for some time yet. There are
commercial sources of anti-GST antibodies, but they're raised against the
human antigen, and according to Pharmacia, don't cross react with the S.
japonicum antigen. Your best bet is to express pGEX, purify GST from
the supernatant, and immunize a rabbit with it.

Depending on various things, I _may_ have some anti-GST by January next
year
(I'm currently immunizing with a fusion protein). Ask me later!

Regarding your expression problems, I found out that _most_ fusion
proteins
are insoluble and are found in inclusion bodies, _not_ the supernatant (as
stated in Smith and Johnson (or indeed, Current Protocols in Molecular
Biology). See Fiona Marston's articles in Biochem J. (1986) 240, 1-12 and
an article of the same name in another journal (don't have the reference
at hand, unfortunately!). Also, Nagai and Thogersen (1987) Methods Enzymol
153, 461-481 for inclusion body prep. As a first step, you may want to
boil some of the pellet to see if the fusion protein is actually being
produced, but in an insoluble form.

Good luck!

=======================================================================
=======
Chong-Yee Khoo                             E-mail: cyk10@cus.cam.ac.uk
Wellcome/CRC Institute                     Talk:  
cyk10@cy-mac.welc.cam.ac.uk
Tennis Court Road                          Phone:  +44 223 334110
Cambridge                                  Fax:    +44 223 334089
CB2 1QR

From owner-proteins@net.bio.net Thu Nov 12 22:00:00 1992
Path: biosci!NBRF.GEORGETOWN.EDU!POSTMASTER
From: POSTMASTER@NBRF.GEORGETOWN.EDU
Newsgroups: bionet.molbio.proteins
Subject: Temporary Interruption of BITNET Access to PIR
Message-ID: <01GR3OH7XZYQ94DQ9J@NBRF.Georgetown.Edu>
Date: 13 Nov 92 15:50:36 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 25


            Announcement of Temporary Interruption of Access to
                     The Protein Information Resource

The National Biomedical Research Foundation will not have direct access to
BITNET from 17:00 EST Friday 20 November through about 12:00 EST Monday 23
November because of a system upgrade to be performed on a connecting node.
Users who normally access the PIR Network Request Server through BITNET
channels can expect a delay in response until full channel operation is
restored.

This interruption will not affect our On-line System users or users who
normally access the server through Internet channels.  BITNET users may
wish to attempt to access our server through a gateway at the Internet address
FILESERV@NBRF.GEORGETOWN.EDU

We regret any inconvenience this temporary loss of service will cause.
------------------------------------------------------------------------
                                 Dr. John S. Garavelli
                                 Database Coordinator
                                 Protein Information Resource
                                 National Biomedical Research Foundation
                                 Washington, DC  20007
                                 POSTMASTER@GUNBRF.BITNET
                                 POSTMASTER@NBRF.GEORGETOWN.EDU

From owner-proteins@net.bio.net Sat Nov 14 22:00:00 1992
Path: biosci!daresbury!doc.ic.ac.uk!agate!spool.mu.edu!umn.edu!bru!minsky!raja
From: raja@mayo.edu (Raja Muthupillai, BIR Grad Student, Dr. Robb)
Newsgroups: bionet.molbio.proteins
Subject: Request for info reg. resources In article
Message-ID: <1992Nov15.234117.11661@bmw.mayo.edu>
Date: 15 Nov 92 23:41:17 GMT
References: <12NOV199215143452@aardvark.ucs.uoknor.edu>
Sender: newsman@bmw.mayo.edu (/home/bmw/usenet)
Reply-To: raja@mayo.edu
Organization: Mayo Foundation
Lines: 13


Hi,

I am new to the newsgroups in the field of molecular biology.
I am very much interested in the resources availble in the network,
for researchers in molecular biology.  I'd greatly appreciate any
relevant information.

If anyone wants to send it directly, please do so.
My email address raja@mayo.edu

Thanks,
Raja.

From owner-proteins@net.bio.net Sun Nov 15 22:00:00 1992
Path: biosci!uwm.edu!rpi!crdgw1!rdsunx.crd.ge.com!maxwell!ebstokes
From: ebstokes@maxwell.crd.ge.com (Ed Stokes)
Newsgroups: bionet.molbio.proteins
Subject: tryp in IgG ?
Message-ID: <1992Nov16.162558.20257@crd.ge.com>
Date: 16 Nov 92 16:25:58 GMT
Sender: usenet@crd.ge.com (Required for NNTP)
Organization: GE Corp. Research & Development, Schenectady, NY
Lines: 14
Nntp-Posting-Host: maxwell.crd.ge.com

I am a physicist investigating the binding and optical properties
of antibodies for possible sensor applications. My understanding
is that if an IgG antibody contains tryptophan in the binding
pocket, then the perturbation of the tryptophan luminescence
properties can be used to identify an antigen binding event.

Are the sequences of IgG's from various species and for various
antigens known ? How can I know whether there are luminescent
amino acid residues in the binding pocket of a particular
antibody ? Can these properties be engineered ?

Thanks
Ed Stokes
ebstokes@crd.ge.com

From owner-proteins@net.bio.net Mon Nov 16 22:00:00 1992
Path: biosci!agate!spool.mu.edu!yale.edu!ira.uka.de!ira.uka.de!news.belwue.de!news.uni-ulm.de!news
From: ORTIGAO@rzmain.rz.uni-ulm.de (ORTIGAO FLAVIO)
Newsgroups: bionet.molbio.proteins
Subject: Solid-phase peptide modification
Message-ID: <1992Nov17.190845.19153@wega.rz.uni-ulm.de>
Date: 17 Nov 92 19:08:45 GMT
Sender: news@wega.rz.uni-ulm.de (News Net)
Organization: University of Ulm, Germany
Lines: 13
X-News-Reader: VMS NEWS 1.24

Dear collegues:
I am looking for methods, compatible wiht Fmoc-chemistry to derivatize a peptide
with a handle, which could be used to attach the growing peptide covalently into
a different surface. Ideally the handle should be introduced while the peptide
is still protected. Even better it should be cleaved from support while still
protected, and would be deprotected after the coupling to the new surface.
I would appreciate any help.
Thanks in advance, Flavio
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Dr. J.F. Ramalho Ortigao
University of Ulm
Sektion Polymere
D-7900 Ulm, Germany

From owner-proteins@net.bio.net Mon Nov 16 22:00:00 1992
Path: biosci!BRI.NRC.CA!Carlos.Faerman
From: Carlos.Faerman@BRI.NRC.CA (Carlos Faerman)
Newsgroups: bionet.molbio.proteins
Subject: General Question
Message-ID: <9211171928.AA28422@bobino.BRI.NRC.CA>
Date: 17 Nov 92 19:28:44 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 8

I would like to find out whether a tabulation of the second-order rate
constants for enzymes is available. In other words, I would be very happy
to find a Table that lists Kcat/Km for a large set of the known
enzymes.
I look forward to hearing from you.

e-mail: carlos@bri.nrc.ca


From owner-proteins@net.bio.net Mon Nov 16 22:00:00 1992
Path: biosci!agate!spool.mu.edu!uunet!seas.gwu.edu!merlot.gwu.edu!danj
From: danj@merlot.gwu.edu (Dan Jacobson )
Newsgroups: bionet.molbio.proteins
Subject: Re: tryp in IgG ?
Message-ID: <1992Nov17.165646.26056@seas.gwu.edu>
Date: 17 Nov 92 16:56:46 GMT
References: <1992Nov16.162558.20257@crd.ge.com>
Sender: news@seas.gwu.edu
Organization: George Washington University, Washington, D.C.
Lines: 83

In article <1992Nov16.162558.20257@crd.ge.com> ebstokes@maxwell.crd.ge.com (Ed Stokes) writes:
>I am a physicist investigating the binding and optical properties
>of antibodies for possible sensor applications. My understanding
>is that if an IgG antibody contains tryptophan in the binding
>pocket, then the perturbation of the tryptophan luminescence
>properties can be used to identify an antigen binding event.
>
>Are the sequences of IgG's from various species and for various
>antigens known ? How can I know whether there are luminescent
>amino acid residues in the binding pocket of a particular
>antibody ? Can these properties be engineered ?
>
>Thanks
>Ed Stokes
>ebstokes@crd.ge.com


Umm - first off I think you're talking about fluorescence -

the emission of or the property of emission of or the property of
emitting electromagnetic radiation usu. as visible light resulting from
and only during the absorption of radiation from some other source

rather than luminescence - 

an emission of light that is not
ascribable directly to incandescence and therefore occurs at low
temperatures and that is produced by physiological processes (as in the
firefly), by chemical action, by friction, or by electrical action.

With that minor clarification aside - yes the sequences for some species
and some antigens are known.  As a starting point I suggest that you
take a look at the sequences that are in the databases - a quick search
of Genbank for IgG yeilds the following list. Note that many of these
sequences are IgG RECEPTORS etc.. not IgG itself.


      1.  IIMSG1 IgG1 induction factor precursor - Mouse.
      2.  QVSAA Protein A precursor - Staphylococcus aureus.
      3.  A24496 IgG-binding protein - Streptococcus sp. (group G).
      4.  A26314 Protein G - Streptococcus sp. (fragment).
      5.  A26555 Ig heavy chain V region (Ger) - Human (fragment).
      6.  B25521 Ig kappa chain precursor V region (305) - Human.
      7.  A25521 Ig kappa chain V region (321) - Human (fragment).
      8.  B26555 Ig kappa chain V-III region (Ger) - Human.
      9.  S03018 IgG Fc receptor (clone p135) - Human.
      10. S03019 IgG Fc receptor (clone p98/X2) - Human.
      11. A31932 IgG Fc receptor precursor - Human.
      12. JU0284 IgG Fc receptor precursor, type III-1.
      13. JL0107 IgG Fc receptor precursor, type III-2 (NK cells) -.
      14. JH0429 IgG light chain V region VKIIIb-T14 - Human.
      15. S00477 Surface glycoprotein CDw32 precursor (clone PC23) -.
      16. S00478 Surface glycoprotein CDw32 precursor (clone TC3) -.
      17. S02297 Surface glycoprotein CDw32 precursor - Human.
      18. PT0356 IgG kappa chain V region 2B11.1 - Mouse (fragment).
      19. PT0358 IgG kappa chain V region 7D2.G12 - Mouse (fragment).
      20. PT0357 IgG kappa chain V region C8.5 - Mouse (fragment).
      21. PT0359 IgG kappa chain V region R4A.12 - Mouse (fragment).
      22. A35902 Fc gamma (IgG) receptor II (low affinity) alpha.
      23. S02117 IgG Fc receptor 51K chain precursor - Rat.
      24. A33939 *IgG Fc receptor II precursor - Streptococcus sp..
      25. A39041 *IgG-binding protein - Streptococcus sp. (group G).
      26. S20760 *IgG heavy chain (5.7S ) - Duck.
      27. S20759 *IgG heavy chain (7.8S) - Duck.
      28. A39878 *CD64 (high affinity IgG receptor) precursor - Human.
      29. B41357 *Fc-gamma (IgG) receptor I (high affinity) - Human.
      30. A41357 *Fc-gamma (IgG) receptor I (high affinity) form b -.
      31. S06946 *IgG Fc receptor - Human.
      32. JL0118 *IgG Fc receptor IIa (CD32) precursor - Human.
      33. A32933 *IgG receptor CD16 (clone HL12) - Human (fragment).
      34. S13852 *CD4-IgG - Chinese hamster.
      35. A40071 *Fc gamma (IgG) receptor II (low affinity) beta-1.
      36. B40071 *Fc gamma (IgG) receptor II (low affinity) beta-2.
      37. A35944 *IgG heavy chain 2a - Mouse (fragment).



Best of luck,


Dan Jacobson

danj@chablis.gwu.edu

From owner-proteins@net.bio.net Mon Nov 16 22:00:00 1992
Path: biosci!QMS1.LIFE.UIUC.EDU!Dan_Szymanski
From: Dan_Szymanski@QMS1.LIFE.UIUC.EDU ("Dan Szymanski")
Newsgroups: bionet.molbio.proteins
Subject: TCA precipitations
Message-ID: <199211180207.AA03982@ux1.cso.uiuc.edu>
Date: 18 Nov 92 02:05:04 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 10


                       Subject:                               Time:7:59 PM
  OFFICE MEMO          TCA precipitations                     Date:11/17/92
wondering.... does TCA precipitate things in a way similar to ammonium sulfate?
 who knows the real story?  further, what would are the characteristics of a
protein that is soluable in low percentage solutions of TCA?  highly charged?
h-bonding characteristics? stability/solvent acccesiblity? so many questions. 
thanks for any responses



From owner-proteins@net.bio.net Mon Nov 16 22:00:00 1992
Path: biosci!QMS1.LIFE.UIUC.EDU!Dan_Szymanski
From: Dan_Szymanski@QMS1.LIFE.UIUC.EDU ("Dan Szymanski")
Newsgroups: bionet.molbio.proteins
Subject: competitive inhibition
Message-ID: <199211180238.AA07191@ux1.cso.uiuc.edu>
Date: 18 Nov 92 02:22:03 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 16


                       Subject:                               Time:7:59 PM
  OFFICE MEMO          competitive inhibition                 Date:11/17/92
to the net:
i am looking for a reference that will help in designing an gel mobility shift
experiment that will allow me to calculate the equilibrium binding constant of
a ligand (dna binding protein) for a competitor (different DNA polymers)
knowing the the eq. binding constant for a high affinity site with constrained
sequence.  i know im looking at around 10 -8 to 10 -9 for the high affinity
site, and the competitors will be within an order of magnitude, or two at the
most. 
sincerely,
molecular biologist with a cause,
dan



From owner-proteins@net.bio.net Tue Nov 17 22:00:00 1992
Path: biosci!uwm.edu!cs.utexas.edu!uunet!comp.vuw.ac.nz!am.dsir.govt.nz!lincoln.cri.nz
From: srckuxw@lincoln.cri.nz
Newsgroups: bionet.molbio.proteins
Subject: peptide analysis
Message-ID: <2b0b9211.d40@lincoln.cri.nz>
Date: 19 Nov 92 00:09:37 GMT
Organization: Canty Ag & Science Centre, New Zealand.
Lines: 12

Dear colleagues

I am interested in the glycosylation of a protein. My idea is to separate a
tryptic (or other) digest of my protein on a polyacrylamide gel, blot them on a
PVDF Membrane and screen the membrane afterwards for glycosylated peptides. Has
anybody experiance with that kind of work. I am manly interested in hints how
to bind small peptides (smaller than 10K) on membranes.
Thanks in advance
                         Urs Waefler
                         Crop & Food Research
                         Lincoln
                         New Zealand

From owner-proteins@net.bio.net Tue Nov 17 22:00:00 1992
Path: biosci!uwm.edu!zaphod.mps.ohio-state.edu!ub!galileo.cc.rochester.edu!news
From: DSCT@db1.cc.rochester.edu (DAVID SCOTT)
Newsgroups: bionet.molbio.proteins
Subject: Re: TCA precipitations
Message-ID: <1992Nov18.215322.4034@galileo.cc.rochester.edu>
Date: 18 Nov 92 21:53:22 GMT
References: <199211180207.AA03982@ux1.cso.uiuc.edu>
Sender: news@galileo.cc.rochester.edu
Organization: University of Rochester, Rochester NY
Lines: 15
In-Reply-To: Dan_Szymanski@QMS1.LIFE.UIUC.EDU's message of 18 Nov 92 02:05:04 GMT
Nntp-Posting-Host: db4.cc.rochester.edu
X-News-Reader: VMS NEWS 1.11

In <199211180207.AA03982@ux1.cso.uiuc.edu> Dan_Szymanski@QMS1.LIFE.UIUC.EDU writes:

> 
>                        Subject:                               Time:7:59 PM
>   OFFICE MEMO          TCA precipitations                     Date:11/17/92
> wondering.... does TCA precipitate things in a way similar to ammonium sulfate?
>  who knows the real story?  further, what would are the characteristics of a
> protein that is soluable in low percentage solutions of TCA?  highly charged?
> h-bonding characteristics? stability/solvent acccesiblity? so many questions. 
> thanks for any responses

	TCA and ammonium sulfate do not precipitate in the same way.  TCA
irreversibly denatures proteins whereas amm. sulf. does not. Amm. sulf.
ppt.ated proteins can be readily redissolved in physiological buffers.  Can't
help with the rest. Sorry

From owner-proteins@net.bio.net Thu Nov 19 22:00:00 1992
Path: biosci!UH.EDU!Davison
From: Davison@UH.EDU (Dan Davison)
Newsgroups: bionet.molbio.proteins
Subject: Re: Looking for a protein secondary-structure databank
Message-ID: <199211201918.AA02210@Menudo.UH.EDU>
Date: 20 Nov 92 19:18:38 GMT
References: <01GRDFUI6I8I94DSOM@NBRF.Georgetown.Edu>
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 29

POSTMASTER@NBRF.Georgetown.Edu said:
> Release 9.1 of NRL_3D is available through the PIR Network Request Server,
> through the PIR On-Line Access System and by FTP from the University
> of Houston server at ftp.bchs.uh.edu in the files
>   /pub/gene-server/incoming/pir33/nrl_3d-9.1-vms
>   /pub/gene-server/incoming/pir33/nrl_3d-9.1-ascii
> Our thanks to Bill Pearson and Dan Davison for their efforts in
> providing FTP access to the PIR databases.


The files are moved; they are in 
pub/gene-server/pir/pir_rel34/vms or
pub/gene-server/pir/pir_rel34/ascii
as compressed files (nrl_*.Z). Be sure to use "binary" mode when
transferring the files.

dan



-- 
dr. dan davison/dept. of biochemical and biophysical sciences/univ. of
Houston/4800 Calhoun/Houston,TX 77204-5934/davison@uh.edu/DAVISON@UHOU

-----RIP Isaac Asimov 1920-1992     I'll miss him --------------------

Disclaimer: As always, I speak only for myself, and, usually, only to
myself.


From owner-proteins@net.bio.net Thu Nov 19 22:00:00 1992
Path: biosci!uwm.edu!spool.mu.edu!darwin.sura.net!Sirius.dfn.de!news.uni-bielefeld.de!asl.uni-bielefeld.de!karsten
From: karsten@asl.uni-bielefeld.de (Karsten Quast)
Newsgroups: bionet.molbio.proteins
Subject: Looking for a protein secondary-structure databank
Message-ID: <By0H92.DLo@hermes.hrz.uni-bielefeld.de>
Date: 20 Nov 92 11:00:37 GMT
Sender: news@hermes.hrz.uni-bielefeld.de (News Administrator)
Organization: Universitaet Bielefeld, ASL.
Lines: 9
Nntp-Posting-Host: liliasl1.uni-bielefeld.de

Hi,

I,m looking for a databank which contains protein secondary-structure data.
I'd like to implement a neural network which predicts secondary-structure
and need very much data for the training.

Thanks in advance for any responses

					Karsten

From owner-proteins@net.bio.net Thu Nov 19 22:00:00 1992
Path: biosci!NBRF.GEORGETOWN.EDU!POSTMASTER
From: POSTMASTER@NBRF.GEORGETOWN.EDU
Newsgroups: bionet.molbio.proteins
Subject: Re: Looking for a protein secondary-structure databank
Message-ID: <01GRDFUI6I8I94DSOM@NBRF.Georgetown.Edu>
Date: 20 Nov 92 16:18:18 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 53

Karsten Quast in message <9211201109.AA11655@net.bio.net> pleads

> I,m looking for a databank which contains protein secondary-structure data.
> I'd like to implement a neural network which predicts secondary-structure
> and need very much data for the training.

The PIR's NRL_3D database is an integrated database of protein sequence and
secondary structure information using all of the Brookhaven Protein Data Bank. 
The caveat is that the annotated secondary structure information is only what
appears in the Brookhaven Protein Data Bank.  Since that information was
provided by the depositors, it is not necessarily complete (not all sequences
are annotated for all features, so the absence of a feature for a particular
sequence can't be taken as meaning that structure is not present) or consistent
(some depositors may interpret what is essentially the same structure in
different ways.)  The following is a description of the features annotations in
the NRL_3D database from one of our recent announcements.  The current version
of NRL_3D is 10.00 it corresponds to Brookhaven Protein Data Bank Release 61,
and contains 1,457 sequences with 244,804 residues.
------------------------------------------------------------------------
2. NRL_3D Release 9.1 Has Feature Information from Brookhaven Data Bank

The NRL_3D Database of sequence information extracted from the Brookhaven
Protein Data Bank (PDB) has been upgraded to release 9.1.  This new version
includes feature annotations extracted from PDB HELIX, SHEET, TURN, SITE, and
SSBOND records along with special ATOM and HETATM records.  New algorithms
have been implemented to construct and name chains and fragments, to recognize
non-standard residues and to discard entries with completely unknown sequence.
NRL_3D release 9.1 corresponds to PDB release 60 (May 1992) and contains
1,380 sequences with 229,099 residues.

The inclusion of this feature information in NRL_3D allows PDB entries to be
recovered through the FEATURE command.  For example the commands
  USE BASES NRL_3D
  FEATURE TURN "TYPE I "
will list all entries in the NRL_3D database with a "type I" turn annotated
in their corresponding PDB entry.

Release 9.1 of NRL_3D is available through the PIR Network Request Server,
through the PIR On-Line Access System and by FTP from the University of Houston 
server at ftp.bchs.uh.edu in the files
  /pub/gene-server/incoming/pir33/nrl_3d-9.1-vms
  /pub/gene-server/incoming/pir33/nrl_3d-9.1-ascii

Our thanks to Bill Pearson and Dan Davison for their efforts in providing FTP
access to the PIR databases.
------------------------------------------------------------------------
                                 Dr. John S. Garavelli
                                 Database Coordinator
                                 Protein Information Resource
                                 National Biomedical Research Foundation
                                 Washington, DC  20007
                                 POSTMASTER@GUNBRF.BITNET
                                 POSTMASTER@NBRF.GEORGETOWN.EDU

From owner-proteins@net.bio.net Thu Nov 19 22:00:00 1992
Path: biosci!QMS1.LIFE.UIUC.EDU!Dan_Szymanski
From: Dan_Szymanski@QMS1.LIFE.UIUC.EDU ("Dan Szymanski")
Newsgroups: bionet.molbio.proteins
Subject: TCA precipitations
Message-ID: <199211201510.AA15392@ux1.cso.uiuc.edu>
Date: 20 Nov 92 15:09:37 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 10


                       Subject:                               Time:7:59 PM
  OFFICE MEMO          TCA precipitations                     Date:11/17/92
wondering.... does TCA precipitate things in a way similar to ammonium sulfate?
 who knows the real story?  further, what would are the characteristics of a
protein that is soluable in low percentage solutions of TCA?  highly charged?
h-bonding characteristics? stability/solvent acccesiblity? so many questions. 
thanks for any responses



From owner-proteins@net.bio.net Sun Nov 22 22:00:00 1992
Path: biosci!uwm.edu!caen!uunet!mcsun!news.funet.fi!hydra!klaava!tolvanen
From: tolvanen@klaava.Helsinki.FI (Martti Tolvanen)
Newsgroups: bionet.molbio.proteins
Subject: New PDB entries
Message-ID: <1992Nov23.135345.29653@klaava.Helsinki.FI>
Date: 23 Nov 92 13:53:45 GMT
Organization: University of Helsinki
Lines: 11

I just read in Nature, Nov.  19, (360:232-239) about a crystal structure
of CD2 that has been deposited in the Protein Data Bank, and of course I
went ahead and checked the prerelease area in their ftp site
(pdb.pdb.bnl.gov).  Searching for cd2 in the NOTICE.UPDATE file or in
the filenames gave nothing, though. 

Does anyone have an idea how long it takes to process a submitted entry
into a prerelease entry?
-- 
Martti Tolvanen, Dept. Biochem., Univ. Helsinki, Finland
tolvanen@cc.helsinki.fi

From owner-proteins@net.bio.net Mon Nov 23 22:00:00 1992
Path: biosci!lhc!lhc!hunter
From: hunter@work.nlm.nih.gov (Larry Hunter)
Newsgroups: bionet.molbio.proteins
Subject: Re: Looking for a protein secondary-structure databank
Message-ID: <HUNTER.92Nov24094247@work.nlm.nih.gov>
Date: 24 Nov 92 17:42:47 GMT
References: <By0H92.DLo@hermes.hrz.uni-bielefeld.de>
Sender: news@nlm.nih.gov
Organization: National Library of Medicine
Lines: 42
In-Reply-To: karsten@asl.uni-bielefeld.de's message of Fri, 20 Nov 1992 11:00:37 GMT


karsten@asl.uni-bielefeld.de writes:

  I,m looking for a databank which contains protein secondary-structure data.
  I'd like to implement a neural network which predicts secondary-structure and
  need very much data for the training.

As noted previously, the NRL-3D dataset (available from the UH server) is one
way to get structural information.  Another is to get the PDB dataset itself
directly from Brookhaven, either by email server (fileserv@pb1.pdb.bnl.gov) or
anonymous ftp (pdb.pdb.bnl.gov).  I believe there is also a gopher hole at
Brookhaven.  Write pdb@chm.chm.bnl.gov for more information.  If you are going
to use these "raw" sources of data, I would strongly recommend getting Laura
Lynn Walsh's PDB info file, which has very useful annotation of each structure.
It is available from her by writing lwalsh@nemo.life.uiuc.edu.

It is also possible to get precisely the same dataset that Qian & Sejnowski
used for their neural network secondary structure prediction paper [J. Mol.
Bio. (1988) 202:865-884] which is available via the University of California,
Irvine machine learning archive.  Anonymous ftp to host ics.uci.edu, directory
/pub/machine-learning-databases/molecular-biology/protein-secondary-structure/
I believe this archive is mirrored by the hosts cs.dal.ca in Canada, and by
src.doc.ic.ac.uk in the UK.

You may also want to check Zhang, Mesirov and Waltz's "Hybrid Systems for
Protein Secondary Structure Prediction," [J. Mol. Bio. (1992) 225:1049-1063]
for the training and test sets that they used, which were quite carefully
selected. 

Best of luck,

	Larry

--
Lawrence Hunter, PhD.
National Library of Medicine
Bldg. 38A, MS-54
Bethesda. MD 20894 USA
tel: +1 (301) 496-9300
fax: +1 (301) 496-0673 
internet: hunter@nlm.nih.gov
encryption: PGP 2.0 public key via "finger hunter@work.nlm.nih.gov"

From owner-proteins@net.bio.net Tue Nov 24 22:00:00 1992
Path: biosci!uwm.edu!caen!uunet!olivea!charnel!sifon!VM1.MCGILL.CA
From: EH26005@MUSICA.MCGILL.CA (EH26005)
Newsgroups: bionet.molbio.proteins
Subject: Molten Globule State of Porin
Message-ID: <25NOV92.21918560.0057@VM1.MCGILL.CA>
Date: 26 Nov 92 01:17:41 GMT
Sender: usenet@MUSICA.MCGILL.CA
Organization: McGill University
Lines: 15
Nntp-Posting-Host: vm1.mcgill.ca


Porins are a family of bacterial outer membrane proteins organized as
16 anti-parallel b-strands that are joined by a salt bridge at the NH2
and COOH terminii to form a transmembrane B-barrel.

I would like to know if such a structure can exist in a molten globule
state.  Any references to studies on the molten-globule state of
proteins organized as B-sheets would be helpful.  Speculation on the
properties of porin in the molten globule state would also be
appreciated: would we have a B-barrel that was opened up by breakage of
the COOH terminus salt bridge? ; what about the hydrogen bonding
between strands?  Any ideas would be welcome.

Dave Dahan
EH26005@MUSICA.MCGILL.CA

From owner-proteins@net.bio.net Tue Nov 24 22:00:00 1992
Path: biosci!QMS1.LIFE.UIUC.EDU!Dan_Szymanski
From: Dan_Szymanski@QMS1.LIFE.UIUC.EDU ("Dan Szymanski")
Newsgroups: bionet.molbio.proteins
Subject: TCA?????
Message-ID: <199211251621.AA15027@ux1.cso.uiuc.edu>
Date: 25 Nov 92 16:10:03 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 10


                       Subject:                               Time:7:59 PM
  OFFICE MEMO          TCA?????                               Date:11/17/92
wondering.... does TCA precipitate things in a way similar to ammonium sulfate?
 who knows the real story?  further, what are the characteristics of a protein
that is soluable in low percentage solutions of TCA?  highly charged? h-bonding
characteristics? stability/solvent acccesiblity? so many questions.  thanks for
any responses



From owner-proteins@net.bio.net Tue Nov 24 22:00:00 1992
Path: biosci!uwm.edu!caen!uunet!utcsri!torn!csd.unb.ca!UNBVM1.CSD.UNB.CA
From: E85J@UNB.CA (E85J000)
Newsgroups: bionet.molbio.proteins
Subject: RSV/Tyler Jacks
Message-ID: <25NOV92.21205996.0082@UNBVM1.CSD.UNB.CA>
Date: 25 Nov 92 23:38:06 GMT
Sender: usenet@UNB.CA
Organization: The University of New Brunswick
Lines: 10

Has anyone out there seen any recent articles from Tyler Jacks since
hisoriginal work with ribosomal frameshifting in RSV's gag-poL?  I
haven't been able to find anything since the Cell 55(447-458) paper
in 1988 on the signals for frameshifting.  I've been doing a lot of
work recently on a term paper on the subject and haven't been able to
find anything, though his work up to '88 seems top notch.

Thanks in advance,

                  pat f.  (E85J@UNB.CA)

From owner-proteins@net.bio.net Tue Nov 24 22:00:00 1992
Path: biosci!XIBALBA.CSHL.ORG!mzhang
From: mzhang@XIBALBA.CSHL.ORG (Michael Zhang)
Newsgroups: bionet.molbio.proteins
Subject: motifs
Message-ID: <9211251824.AA06428@xibalba.cshl.org>
Date: 25 Nov 92 18:24:42 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 4

Is there any protein or DNA sequence motifs database (or collections) available
in the network?
-Michael Zhang
 mzhang@cshl.org

From owner-proteins@net.bio.net Wed Nov 25 22:00:00 1992
Path: biosci!uwm.edu!cs.utexas.edu!uunet!pipex!demon!nuntius
From: pettsj@visigoth.demon.co.uk (James Petts)
Newsgroups: bionet.molbio.proteins
Subject: ras/GTP
Message-ID: <ByBD7n.C6y@gate.demon.co.uk>
Date: 26 Nov 92 08:06:58 GMT
Sender: news@gate.demon.co.uk (Usenet Administration)
Organization: No Affiliation
Lines: 9
X-Useragent: Nuntius v1.1
Nntp-Posting-Host: visigoth.demon.co.uk

Off the top of their head, does anybody have a rough idea of the binding 
constant for GTP to ras p21, and alsao the intracellular conc. of GTP?

James Petts

********************************************************************
* "We use the classical theory on Mondays, Wednesdays and Fridays, *   
*  and the quantum theory on Tuesdays, Thursdays and Saturdays."   *
************************************** Wm. Bragg *******************

From owner-proteins@net.bio.net Wed Nov 25 22:00:00 1992
Path: biosci!BIOTECHNET.COM!MWRAVERA
From: MWRAVERA@BIOTECHNET.COM
Newsgroups: bionet.molbio.proteins
Subject: Tryptophan residues in IgG
Message-ID: <01GRMKU0D37M8WWNLI@delphi.com>
Date: 27 Nov 92 05:29:42 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 26

Recently, a question was asked by Ed Stokes about finding tryptophan residues in the antigen binding pockets of IgG molecules.  One suggestion was to pull all of the IgG sequences out of GenBank to see what could be seen.  I would like to suggest an alte
rnate, admittedly "lower tech" approach.

There is a book (now actually in three volumes) published by the US Govt. Printing Office entitled "Sequences of Proteins of Immuno- logical Interest" edited by Kabat et al.  The advantage of this book over a collection of GenBank sequences is that the e
ditors have layed out the sequences (both DNA and protein) logically and with easy-to-find landmarks.

In Ed's case, he would look under the section entitled "Immuno- globin Variable Regions."  There, the sequences are laid out with labels for framework and CDR (hypervariable) subregions.  While this simplifies finding the CDRs (which are the antigen-bind
ing portions of the antibody), it still requires the intrepid researcher to manually look for tryptophan residues.  Call it "good news, bad news..."

I can only hope that some relational database guru (or some whiz kid working on a senior project) will soon allow us to ask a data-base questions such as "Show Ig sequences that contain tryptophan residues in the CDR regions."


Mark


=================================================================
|                        Mark W. Ravera                         |
|                   Sandoz Research Institute                   |
|                                                               |
| USMailNet:         		InterNet: MWRAVERA@BioTechNet.Com |
|  59 Route 10  			PhoneNet: 201-503-8613                       |
|  East Hanover, NJ			FaxNet  : 201-503-6870                    |
|			  19406		InterStateNet: I-287, New Joisey  |
|									Exit 30            |
|						VoiceNet: "Hey, Mark!"                                   |
=================================================================

From owner-proteins@net.bio.net Thu Nov 26 22:00:00 1992
Path: biosci!SMITHKLINE.COM!carpenter_dd%frgen.dnet
From: carpenter_dd%frgen.dnet@SMITHKLINE.COM
Newsgroups: bionet.molbio.proteins
Subject: (none)
Message-ID: <9211272202.AA09564@smithkline.com>
Date: 27 Nov 92 22:02:01 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 2

help


From owner-proteins@net.bio.net Sun Nov 29 22:00:00 1992
Path: biosci!UCRVM2.bitnet!GPAZ
From: GPAZ@UCRVM2.bitnet (Gisela Mabel Paz)
Newsgroups: bionet.molbio.proteins
Subject: Suscripcion
Message-ID: <9211301951.AA02442@net.bio.net>
Date: 30 Nov 92 19:51:57 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 4

Estoy interesada en recibir informacion sobre analisis de proteinas.
especificamente de isoenzimas.
                              Gracias.
                                      Mabel

